Adverum Biotechnologies, Inc. Current Assets
Adverum Biotechnologies, Inc. had Current Assets of $28.91 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-11-12
- 2025-09-30: Assets, Current $28.91M.
- 2025-06-30: Assets, Current $48.39M.
- 2025-03-31: Assets, Current $89.47M.
- 2024-12-31: Assets, Current $131.30M.
| Period end | Assets, Current |
|---|---|
| 2025-09-30 | $28.91M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $48.39M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $89.47M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $131.30M 10-Q · filed 2025-11-12 |
| 2024-09-30 | $161.08M 10-K · filed 2025-04-15 |
| 2024-06-30 | $179.42M 10-K · filed 2025-04-15 |
| 2024-03-31 | $199.13M 10-K · filed 2025-04-15 |
| 2023-12-31 | $102.77M 10-K · filed 2025-04-15 |
| 2023-09-30 | $124.60M 10-K · filed 2025-04-15 |
| 2023-06-30 | $147.14M 10-K · filed 2025-04-15 |
| 2023-03-31 | $168.87M 10-K · filed 2025-04-15 |
| 2022-12-31 | $190.59M 10-K · filed 2024-03-18 |
| 2022-09-30 | $213.24M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $246.03M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $280.12M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $317.14M 10-K · filed 2023-03-30 |
| 2021-09-30 | $347.83M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $386.27M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $409.86M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $434.44M 10-K · filed 2022-03-29 |
| 2020-09-30 | $459.70M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $282.68M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $300.45M 10-Q · filed 2020-05-28 |
| 2019-12-31 | $175.87M 10-K · filed 2021-03-01 |
| 2019-09-30 | $167.60M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $180.56M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $193.14M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $208.75M 10-K · filed 2020-03-12 |
| 2018-09-30 | $222.17M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $237.92M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $249.20M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $193.74M 10-K · filed 2019-03-06 |
| 2017-09-30 | $189.52M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $199.64M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $212.64M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $225.27M 10-K · filed 2018-03-06 |
| 2016-09-30 | $235.90M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $243.57M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $249.23M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $260.99M 10-K · filed 2017-03-09 |
| 2015-09-30 | $270.36M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $280.63M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $291.13M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $160.28M 10-K · filed 2016-03-04 |
| 2014-09-30 | $166.33M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $52.90M 10-Q · filed 2014-09-12 |
| 2013-12-31 | $822.00K 10-K · filed 2015-03-05 |